Artificial Intelligence in Drug Treatment

被引:33
作者
Romm, Eden L. [1 ]
Tsigelny, Igor F. [1 ,2 ]
机构
[1] CureMatch Inc, San Diego, CA 92121 USA
[2] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA
来源
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 | 2020年 / 60卷
关键词
artificial intelligence; machine learning; deep learning; personalized medicine; drug combination; combination therapy; BLOOD-BRAIN-BARRIER; FEATURE-SELECTION; PREDICTION; IDENTIFICATION; OPTIMIZATION; POLYPHARMACY; DESCRIPTORS; DATABASE;
D O I
10.1146/annurev-pharmtox-010919-023746
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The most common applications of artificial intelligence (AI) in drug treatment have to do with matching patients to their optimal drug or combination of drugs, predicting drug-target or drug-drug interactions, and optimizing treatment protocols. This review outlines some of the recently developed AI methods aiding the drug treatment and administration process. Selection of the best drug(s) for a patient typically requires the integration of patient data, such as genetics or proteomics, with drug data, like compound chemical descriptors, to score the therapeutic efficacy of drugs. The prediction of drug interactions often relies on similarity metrics, assuming that drugs with similar structures or targets will have comparable behavior or may interfere with each other. Optimizing the dosage schedule for administration of drugs is performed using mathematical models to interpret pharmacokinetic and pharmacodynamic data. The recently developed and powerful models for each of these tasks are addressed, explained, and analyzed here.
引用
收藏
页码:353 / 369
页数:17
相关论文
共 61 条
[21]  
Janizek J.D., 2018, bioRxiv, P331769, DOI DOI 10.1101/331769
[22]   From genomics to chemical genomics: new developments in KEGG [J].
Kanehisa, Minoru ;
Goto, Susumu ;
Hattori, Masahiro ;
Aoki-Kinoshita, Kiyoko F. ;
Itoh, Masumi ;
Kawashima, Shuichi ;
Katayama, Toshiaki ;
Araki, Michihiro ;
Hirakawa, Mika .
NUCLEIC ACIDS RESEARCH, 2006, 34 :D354-D357
[23]   Predicting potential drug-drug interactions on topological and semantic similarity features using statistical learning [J].
Kastrin, Andrej ;
Ferk, Polonca ;
Leskosek, Brane .
PLOS ONE, 2018, 13 (05)
[24]  
KEGG, 2019, KEGG KYOT ENC GEN GE
[25]   An Ant-Lion Optimizer-Trained Artificial Neural Network System for Chaotic Electroencephalogram (EEG) Prediction [J].
Kose, Utku .
APPLIED SCIENCES-BASEL, 2018, 8 (09)
[26]   The SIDER database of drugs and side effects [J].
Kuhn, Michael ;
Letunic, Ivica ;
Jensen, Lars Juhl ;
Bork, Peer .
NUCLEIC ACIDS RESEARCH, 2016, 44 (D1) :D1075-D1079
[27]   Effect of selection of molecular descriptors on the prediction of blood-brain barrier penetrating and nonpenetrating agents by statistical learning methods [J].
Li, H ;
Yap, CW ;
Ung, CY ;
Xue, Y ;
Cao, ZW ;
Chen, YZ .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2005, 45 (05) :1376-1384
[28]   A survey of current trends in computational drug repositioning [J].
Li, Jiao ;
Zheng, Si ;
Chen, Bin ;
Butte, Atul J. ;
Swamidass, S. Joshua ;
Lu, Zhiyong .
BRIEFINGS IN BIOINFORMATICS, 2016, 17 (01) :2-12
[29]   Prediction of synergistic anti-cancer drug combinations based on drug target network and drug induced gene expression profiles [J].
Li, Xiangyi ;
Xu, Yingjie ;
Cui, Hui ;
Huang, Tao ;
Wang, Disong ;
Lian, Baofeng ;
Li, Wei ;
Qin, Guangrong ;
Chen, Lanming ;
Xie, Lu .
ARTIFICIAL INTELLIGENCE IN MEDICINE, 2017, 83 :35-43
[30]  
Lim B, 2018, 32 C NEUR INF PROC S